Direct Acting Antiviral-Post Authorization Safety Study
Clinical trial NCT03707080 · COMPLETED
Trial details
- NCT number
- NCT03707080
- Sponsor
- Target PharmaSolutions, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-03-09
- Primary completion
- 2021-06-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.